TIMP2 ameliorates blood-brain barrier disruption in traumatic brain injury by inhibiting Src-dependent VE-cadherin internalization
Journal of Clinical Investigation · 28.11.2023 · 134 (3)
DOI: 10.1172/jci164199 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 28.11.2023. Verfasst von Jingshu Tang und 9 weiteren Autor:innen. Hauptthemen laut MEDLINE: Antigens, CD, Blood-Brain Barrier, Brain Injuries, Traumatic. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Sciences Foundation of China, CAMS Innovation Fund for Medical Sciences, Disciplines construction project.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Förderung
- National Natural Sciences Foundation of China
- CAMS Innovation Fund for Medical Sciences
- Disciplines construction project
Zitieren
APA
Tang, J., Kang, Y., Zhou, Y., Shang, N., Li, X., Wang, H., Lan, J., Wang, S., Wu, L., & Peng, Y. (2023). TIMP2 ameliorates blood-brain barrier disruption in traumatic brain injury by inhibiting Src-dependent VE-cadherin internalization. Journal of Clinical Investigation, 134(3). https://doi.org/10.1172/jci164199
Vancouver
Tang J, Kang Y, Zhou Y, Shang N, Li X, Wang H, et al. TIMP2 ameliorates blood-brain barrier disruption in traumatic brain injury by inhibiting Src-dependent VE-cadherin internalization. Journal of Clinical Investigation. 2023;134(3). doi:10.1172/jci164199
BibTeX
@article{Tang2023,
author = {Tang, Jingshu and Kang, Yuying and Zhou, Yujun and Shang, Nianying and Li, Xinnan and Wang, Hongyue and Lan, Jiaqi and Wang, Shuai and Wu, Lei and Peng, Ying},
title = {TIMP2 ameliorates blood-brain barrier disruption in traumatic brain injury by inhibiting Src-dependent VE-cadherin internalization},
journal = {Journal of Clinical Investigation},
year = {2023},
volume = {134},
number = {3},
doi = {10.1172/jci164199}
}
EUVIMED